Furthermore, existing studies have only explored the role of USP39 in regulating tumor-related signaling pathways, including PI3K/AKT/HIF-1α and Wnt/β-catenin, across a limited range of cancers, such as hepatocellular carcinoma, endometrial cancer, and ovarian cancer. This evidence concerns the gene USP39 and endometrial cancer.